Jacob Gottlieb: A Real Titan of Healthcare Investments

Jacob Gottlieb is famously known for his unrivaled success in investment and entrepreneurship. He majorly focuses on healthcare investments, which has earned him the title ‘titan of healthcare investing.’ For Gottlieb, the sky is the limit when it comes to the advancement of medical treatments and meaningful health services. As such, he is adding Altium Capital to his endeavors. Altium Capital is a healthcare-based venture focusing on investment opportunities that impart growth of firms in the said sector.

Understanding the Concept of Altium Capital

This enterprise has had several recent investments among them being Oramed Pharmaceuticals (ORMP), Oragenics, and Amarin Corporation (AMRN). Their initial investment in Oramed was a 5.61% stake, which has developed an alternative oral treatment for diabetic patients who depend on injection. Their innovative oral insulin capsule (ORMD-0801) has been tried, tested, and grouped with Glucagon-like peptide-1 (GLP-1), capsule (ORMD-0901), and analog (exenatide).

Amarin is an innovative pharmaceutical firm that seeks to develop cardiovascular drugs. They have experienced rapid growth over time. In 2012, they had their first drug, Vascepa (AMR-101), approved by FDA, and this was among the most significant milestones. Oragenics is also growing quite fast since it was launched in 1996. It borrows from the concept of replacement therapy, which is based on the replacement of destructive microbes with helpful bacteria for enhanced health.

Gottlieb Envisions Healthcare Improvement Day and Night

Throughout his career, Jacob has been fine-tuning his instinct and amazing skills for growth in the healthcare sector. His fingers are always on the pulse of development in this sector, which is evident through his founded ventures. Before the idea of Altium, Jacob had launched Visium Asset Management, a highly successful enterprise that had raised $8 billion by 2016. Although it later shut down due to insider trading by several employees, it did not deter Jacob Gottlieb from pursuing further meaningful investments.

Leave a Reply

Your email address will not be published. Required fields are marked *